In 3951 patients with breast cancer, survival analyses showed that high CD40 mRNA expression was highly associated with improved overall survival (OS) (hazard ratios of 0.62–0.77, P =3.4e-11) (Figure 1a). This evidence concerns the gene CD40 and breast cancer.